Our first innovation, Regulora®, recently received FDA clearance as the first PDT specifically indicated for the treatment of pain associated with IBS through gut-directed hypnotherapy (GDH). We have additional cutting-edge products in our pipeline including PDTs for heartburn and ulcerative colitis. Our digital hypnotherapy has the potential to help with many other common chronic conditions, such as fibromyalgia, cancer pain, migraine, and more.

Prescription digital therapeutics (PDTs) operate at the intersection of biology and technology delivering evidence-based therapeutic interventions through high-quality software programs to prevent, manage, or treat a medical disorder or disease. PDTs incorporate advanced technology best practices for design, clinical evaluation, usability, and data security, and are developed under the same rigorous conditions as pharmaceuticals complete with clinical trials, FDA clearance, and are available only with a physician’s prescription.

PDTs could be a vital part of future treatment models across a range of diseases with unmet medical needs, working alongside prescription medicines to better address the full burden of disease and in some cases even offering solutions where none currently exist.

Twitter Page of the Solution

linkedin Page of the Solution

Website of the Solution